Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

Consensus-based care recommendations for adults with myotonic dystrophy type 1.

Ashizawa T, Gagnon C, Groh WJ, Gutmann L, Johnson NE, Meola G, Moxley R 3rd, Pandya S, Rogers MT, Simpson E, Angeard N, Bassez G, Berggren KN, Bhakta D, Bozzali M, Broderick A, Byrne JLB, Campbell C, Cup E, Day JW, De Mattia E, Duboc D, Duong T, Eichinger K, Ekstrom AB, van Engelen B, Esparis B, Eymard B, Ferschl M, Gadalla SM, Gallais B, Goodglick T, Heatwole C, Hilbert J, Holland V, Kierkegaard M, Koopman WJ, Lane K, Maas D, Mankodi A, Mathews KD, Monckton DG, Moser D, Nazarian S, Nguyen L, Nopoulos P, Petty R, Phetteplace J, Puymirat J, Raman S, Richer L, Roma E, Sampson J, Sansone V, Schoser B, Sterling L, Statland J, Subramony SH, Tian C, Trujillo C, Tomaselli G, Turner C, Venance S, Verma A, White M, Winblad S.

Neurol Clin Pract. 2018 Dec;8(6):507-520. doi: 10.1212/CPJ.0000000000000531. Review.

2.

Utility of Conventional Electrocardiographic Criteria in Patients With Idiopathic Ventricular Tachycardia.

Yadav AV, Nazer B, Drew BJ, Miller JM, El Masry H, Groh WJ, Natale A, Marrouche N, Badhwar N, Yang Y, Scheinman MM.

JACC Clin Electrophysiol. 2017 Jul;3(7):669-677. doi: 10.1016/j.jacep.2017.01.010. Epub 2017 Apr 26.

3.

Rhythm management in myotonic dystrophy: Progress has been made, but unsettled issues remain.

Groh WJ.

Heart Rhythm. 2018 Jul;15(7):969-970. doi: 10.1016/j.hrthm.2018.03.037. Epub 2018 Apr 4. No abstract available.

PMID:
29625279
4.

Correction: Evaluation of the Genetic Basis of Familial Aggregation of Pacemaker Implantation by a Large Next Generation Sequencing Panel.

Celestino-Soper PB, Doytchinova A, Steiner HA, Uradu A, Lynnes TC, Groh WJ, Miller JM, Lin H, Gao H, Wang Z, Liu Y, Chen PS, Vatta M.

PLoS One. 2016 Jan 15;11(1):e0147455. doi: 10.1371/journal.pone.0147455. eCollection 2016. No abstract available.

5.

Evaluation of the Genetic Basis of Familial Aggregation of Pacemaker Implantation by a Large Next Generation Sequencing Panel.

Celestino-Soper PB, Doytchinova A, Steiner HA, Uradu A, Lynnes TC, Groh WJ, Miller JM, Lin H, Gao H, Wang Z, Liu Y, Chen PS, Vatta M.

PLoS One. 2015 Dec 4;10(12):e0143588. doi: 10.1371/journal.pone.0143588. eCollection 2015. Erratum in: PLoS One. 2016;11(1):e0147455.

6.

Arrhythmias in the muscular dystrophies.

Rajdev A, Groh WJ.

Card Electrophysiol Clin. 2015 Jun;7(2):303-8. doi: 10.1016/j.ccep.2015.03.011. Epub 2015 Mar 29. Review.

7.

Contemporary cardiac issues in Duchenne muscular dystrophy. Working Group of the National Heart, Lung, and Blood Institute in collaboration with Parent Project Muscular Dystrophy.

McNally EM, Kaltman JR, Benson DW, Canter CE, Cripe LH, Duan D, Finder JD, Groh WJ, Hoffman EP, Judge DP, Kertesz N, Kinnett K, Kirsch R, Metzger JM, Pearson GD, Rafael-Fortney JA, Raman SV, Spurney CF, Targum SL, Wagner KR, Markham LW; Working Group of the National Heart, Lung, and Blood Institute; Parent Project Muscular Dystrophy.

Circulation. 2015 May 5;131(18):1590-8. doi: 10.1161/CIRCULATIONAHA.114.015151. No abstract available. Erratum in: Circulation. 2015 Jun 23;131(25):e539. Groh, William J [added].

8.

Utilization rates of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death: a 2012 calculation for a midwestern health referral region.

Hoang A, Shen C, Zheng J, Taylor S, Groh WJ, Rosenman M, Buxton AE, Chen PS.

Heart Rhythm. 2014 May;11(5):849-55. doi: 10.1016/j.hrthm.2014.02.019. Epub 2014 Feb 22.

9.

Change in cognitive function over 12 months among patients with an implantable cardioverter-defibrillator.

Kim J, Pressler SJ, Groh WJ.

J Cardiovasc Nurs. 2013 Nov-Dec;28(6):E28-36. doi: 10.1097/JCN.0b013e31829dfc6e.

PMID:
23907140
10.

Arrhythmia management in myotonic dystrophy type 1.

Groh WJ, Bhakta D.

JAMA. 2012 Jul 25;308(4):337-8; author reply 338. doi: 10.1001/jama.2012.6807. No abstract available.

PMID:
22820777
11.

Arrhythmias in the muscular dystrophies.

Groh WJ.

Heart Rhythm. 2012 Nov;9(11):1890-5. doi: 10.1016/j.hrthm.2012.06.038. Epub 2012 Jun 30. Review.

PMID:
22760083
12.

You shouldn't take it with you: postmortem device reuse.

Groh WJ.

Heart Rhythm. 2012 Feb;9(2):215-6. doi: 10.1016/j.hrthm.2011.11.033. Epub 2011 Dec 23. No abstract available.

PMID:
22197682
13.

Pacemaker and implantable cardioverter-defibrillator use in a US myotonic dystrophy type 1 population.

Bhakta D, Shen C, Kron J, Epstein AE, Pascuzzi RM, Groh WJ.

J Cardiovasc Electrophysiol. 2011 Dec;22(12):1369-75. doi: 10.1111/j.1540-8167.2011.02200.x. Epub 2011 Oct 28.

PMID:
22035077
14.

A retrospective analysis of proceduralist-directed, nurse-administered propofol sedation for implantable cardioverter-defibrillator procedures.

Sayfo S, Vakil KP, Alqaqa'a A, Flippin H, Bhakta D, Yadav AV, Miller JM, Groh WJ.

Heart Rhythm. 2012 Mar;9(3):342-6. doi: 10.1016/j.hrthm.2011.10.009. Epub 2011 Oct 12.

PMID:
22001710
15.

Survival and CTG repeat expansion in adults with myotonic dystrophy type 1.

Groh WJ, Groh MR, Shen C, Monckton DG, Bodkin CL, Pascuzzi RM.

Muscle Nerve. 2011 May;43(5):648-51. doi: 10.1002/mus.21934.

PMID:
21484823
16.

Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1.

Groh WJ.

Neurology. 2011 Jan 25;76(4):409; author reply 409. doi: 10.1212/WNL.0b013e3181fe72d7. No abstract available.

PMID:
21263144
17.

Increased mortality with left ventricular systolic dysfunction and heart failure in adults with myotonic dystrophy type 1.

Bhakta D, Groh MR, Shen C, Pascuzzi RM, Groh WJ.

Am Heart J. 2010 Dec;160(6):1137-41, 1141.e1. doi: 10.1016/j.ahj.2010.07.032.

PMID:
21146669
18.

The electrocardiogram: a useful screening test for cardiac involvement in some but not all of the muscular dystrophies.

Groh WJ.

Heart Rhythm. 2010 Oct;7(10):1489-90. doi: 10.1016/j.hrthm.2010.06.031. Epub 2010 Jul 1. No abstract available.

PMID:
20601147
19.

Validity and reliability of the chronic heart failure questionnaire mastery subscale in patients with defibrillators.

Kim J, Pressler SJ, Welch JL, Groh WJ.

West J Nurs Res. 2009 Dec;31(8):1057-75. doi: 10.1177/0193945909338853.

PMID:
19783791
20.

Physical function of patients with implantable cardioverter-defibrillators.

Kim JS, Pressler SJ, Welch JL, Damush T, Sloan RS, Wu J, Groh WJ.

J Cardiovasc Nurs. 2009 Sep-Oct;24(5):398-409. doi: 10.1097/JCN.0b013e3181aa216c.

PMID:
19707100
21.

Arrhythmia exacerbation after sodium channel blockade in myotonic dystrophy type 1.

Otten RF, Scherschel JA, Lopshire JC, Bhakta D, Pascuzzi RM, Groh WJ.

Muscle Nerve. 2009 Nov;40(5):901-2. doi: 10.1002/mus.21345. No abstract available.

PMID:
19623641
22.

Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1.

Groh WJ, Groh MR, Saha C, Kincaid JC, Simmons Z, Ciafaloni E, Pourmand R, Otten RF, Bhakta D, Nair GV, Marashdeh MM, Zipes DP, Pascuzzi RM.

N Engl J Med. 2008 Jun 19;358(25):2688-97. doi: 10.1056/NEJMoa062800.

23.

Pacemaker/implantable cardioverter-defibrillator problem: right ventricular lead missensing in a biventricular implantable cardioverter-defibrillator.

Otten RF, Foreman LD, Groh WJ.

Heart Rhythm. 2008 Jan;5(1):158-9. Epub 2007 Aug 28. No abstract available.

PMID:
18065285
24.

A pilot study in hemodialysis of an electrophysiological tool to measure sudden cardiac death risk.

Friedman AN, Groh WJ, Das M.

Clin Nephrol. 2007 Sep;68(3):159-64.

PMID:
17915618
25.

Synthesis and biodistribution of new radiolabeled high-affinity choline transporter inhibitors [11C]hemicholinium-3 and [18F]hemicholinium-3.

Zheng QH, Gao M, Mock BH, Wang S, Hara T, Nazih R, Miller MA, Receveur TJ, Lopshire JC, Groh WJ, Zipes DP, Hutchins GD, DeGrado TR.

Bioorg Med Chem Lett. 2007 Apr 15;17(8):2220-4. Epub 2007 Feb 4.

PMID:
17303422
26.

Characteristics of volunteers responding to emergencies in the Public Access Defibrillation Trial.

Groh WJ, Birnbaum A, Barry A, Anton A, Mann NC, Peberdy MA, Vijayaraghavan K, Powell J, Mosesso VN Jr; PAD Trial Investigators.

Resuscitation. 2007 Feb;72(2):193-9. Epub 2006 Nov 22.

PMID:
17118512
27.

Evaluation of [11C]hemicholinium-15 and [18F]hemicholinium-15 as new potential PET tracers for the high-affinity choline uptake system in the heart.

Gao M, Miller MA, DeGrado TR, Mock BH, Lopshire JC, Rosenberger JG, Dusa C, Das MK, Groh WJ, Zipes DP, Hutchins GD, Zheng QH.

Bioorg Med Chem. 2007 Feb 1;15(3):1289-97. Epub 2006 Nov 10.

PMID:
17116396
28.

Adverse events associated with lay emergency response programs: the public access defibrillation trial experience.

Peberdy MA, Ottingham LV, Groh WJ, Hedges J, Terndrup TE, Pirrallo RG, Mann NC, Sehra R; PAD Investigators.

Resuscitation. 2006 Jul;70(1):59-65.

PMID:
16784998
29.

ST-segment elevation myocardial infarction: recommendations on triage of patients to heart attack centers: is it time for a national policy for the treatment of ST-segment elevation myocardial infarction?

Henry TD, Atkins JM, Cunningham MS, Francis GS, Groh WJ, Hong RA, Kern KB, Larson DM, Ohman EM, Ornato JP, Peberdy MA, Rosenberg MJ, Weaver WD.

J Am Coll Cardiol. 2006 Apr 4;47(7):1339-45. Epub 2006 Mar 20. Review.

30.
31.

Intrathecal clonidine reduces the incidence of ischemia-provoked ventricular arrhythmias in a canine postinfarction heart failure model.

Issa ZF, Ujhelyi MR, Hildebrand KR, Zhou X, Rosenberger J, Groh WJ, Miller JM, Zipes DP.

Heart Rhythm. 2005 Oct;2(10):1122-7.

PMID:
16188594
32.

Ischemic ventricular arrhythmias during heart failure: a canine model to replicate clinical events.

Issa ZF, Rosenberger J, Groh WJ, Miller JM, Zipes DP.

Heart Rhythm. 2005 Sep;2(9):979-83.

PMID:
16171754
33.

Facile synthesis and PET imaging of a novel potential heart acetylcholinesterase tracer N-[11C]methyl-3-[[(dimethylamino)carbonyl]oxy]-2-(2',2'-diphenylpropionoxymethyl)pyridinium.

Wang JQ, Miller MA, Mock BH, Lopshire JC, Groh WJ, Zipes DP, Hutchins GD, Zheng QH.

Bioorg Med Chem Lett. 2005 Oct 15;15(20):4510-4.

PMID:
16112863
34.

Implementation of community-based public access defibrillation in the PAD trial.

Richardson LD, Gunnels MD, Groh WJ, Peberdy MA, Pennington S, Wilets I, Campbell V, Van Ottingham L, McBurnie MA; PAD Trial Investigators.

Acad Emerg Med. 2005 Aug;12(8):688-97.

35.

A reassuring call.

Beyerbach DM, Groh WJ.

Heart Rhythm. 2005 Aug;2(8):842-3. No abstract available.

PMID:
16051121
36.

Thoracic spinal cord stimulation reduces the risk of ischemic ventricular arrhythmias in a postinfarction heart failure canine model.

Issa ZF, Zhou X, Ujhelyi MR, Rosenberger J, Bhakta D, Groh WJ, Miller JM, Zipes DP.

Circulation. 2005 Jun 21;111(24):3217-20. Epub 2005 Jun 13.

PMID:
15956128
37.

Optical mapping of the functional reentrant circuit of ventricular tachycardia in acute myocardial infarction.

Takahashi T, van Dessel P, Lopshire JC, Groh WJ, Miller J, Wu J, Zipes DP.

Heart Rhythm. 2004 Oct;1(4):451-9.

PMID:
15851199
38.

Factors associated with poor survival in women experiencing cardiac arrest in a rural setting.

Cline SL, von Der Lohe E, Newman MM, Groh WJ.

Heart Rhythm. 2005 May;2(5):492-6.

PMID:
15840473
39.

Familial clustering of muscular and cardiac involvement in myotonic dystrophy type 1.

Groh WJ, Lowe MR, Simmons Z, Bhakta D, Pascuzzi RM.

Muscle Nerve. 2005 Jun;31(6):719-24.

PMID:
15770673
40.

Facile synthesis and initial PET imaging of novel potential heart acetylcholinesterase imaging agents [11C]pyridostigmine and its analogs.

Wang JQ, Miller MA, Fei X, Stone KL, Lopshire JC, Groh WJ, Zipes DP, Hutchins GD, Zheng QH.

Nucl Med Biol. 2004 Oct;31(7):957-64.

PMID:
15464398
41.

Measuring survival rates from sudden cardiac arrest: the elusive definition.

Sayre MR, Travers AH, Daya M, Greene HL, Salive ME, Vijayaraghavan K, Craven RA, Groh WJ, Hallstrom AP; PAD Investigators.

Resuscitation. 2004 Jul;62(1):25-34.

PMID:
15246580
42.

Cardiac function tests in neuromuscular diseases.

Bhakta D, Groh WJ.

Neurol Clin. 2004 Aug;22(3):591-617, vi. Review.

PMID:
15207877
43.

Come see the softer side of clinical outcomes: Quality-of-life measures in implanted defibrillator trials.

Groh WJ, Bhakta D, Lowe MR, Bennett SJ.

J Cardiovasc Electrophysiol. 2004 Mar;15(3):292-4. No abstract available.

PMID:
15030418
44.

Prevalence of structural cardiac abnormalities in patients with myotonic dystrophy type I.

Bhakta D, Lowe MR, Groh WJ.

Am Heart J. 2004 Feb;147(2):224-7.

PMID:
14760317
45.

Increase in ventricular tachycardia frequency after biventricular implantable cardioverter defibrillator upgrade.

Guerra JM, Wu J, Miller JM, Groh WJ.

J Cardiovasc Electrophysiol. 2003 Nov;14(11):1245-7.

PMID:
14678142
46.

A comparison of first-responder automated external defibrillator (AED) application rates and characteristics of AED training.

Lerner EB, Billittier AJ 4th, Shah MN, Newman MM, Groh WJ.

Prehosp Emerg Care. 2003 Oct-Dec;7(4):453-7.

PMID:
14582097
47.

Heart rate variability declines with increasing age and CTG repeat length in patients with myotonic dystrophy type 1.

Hardin BA, Lowe MR, Bhakta D, Groh WJ.

Ann Noninvasive Electrocardiol. 2003 Jul;8(3):227-32.

PMID:
14510658
48.

What's bad for the gander...women and sudden cardiac death.

Groh WJ, von der Lohe E, Zipes DP.

Heart. 2002 Dec;88(6):553-4. No abstract available.

49.

Automated external defibrillator (AED) utilization rates and reasons fire and police first responders did not apply AEDs.

Lerner EB, Billittier AJ 4th, Newman MM, Groh WJ.

Prehosp Emerg Care. 2002 Oct-Dec;6(4):378-82.

PMID:
12385601
50.

Law Enforcement Agency Defibrillation (LEA-D): position statement and best practices recommendations from the National Center for Early Defibrillation.

Newman MM, Mosesso VN Jr, Ornato JP, Paris PM, Andersen L, Brinsfield K, Dunnavant GR, Frederick J, Groh WJ, Johnston S, Lerner EB, Murphy G, Myerburg RJ, Rosenberg DG, Savino M, Sayre MR, Sciammarella J, Schoen V, Vargo P, van Alem A, White RD; National Center for Early Defibrillation.

Prehosp Emerg Care. 2002 Jul-Sep;6(3):346-7. No abstract available.

PMID:
12109582

Supplemental Content

Support Center